• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多参数功能磁共振成像和 F-FDG-PET 预测头颈部鳞状细胞癌患者接受(放)化疗的生存情况。

Multiparametric functional MRI and F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation.

机构信息

Department of Radiology and Nuclear Medicine, Amsterdam UMC, De Boelelaan 1117, Amsterdam, The Netherlands.

Department of Radiology and Nuclear Medicine, Amsterdam UMC, Meibergdreef 9, Amsterdam, The Netherlands.

出版信息

Eur Radiol. 2021 Feb;31(2):616-628. doi: 10.1007/s00330-020-07163-3. Epub 2020 Aug 26.

DOI:10.1007/s00330-020-07163-3
PMID:32851444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7813703/
Abstract

OBJECTIVES

To assess (I) correlations between diffusion-weighted (DWI), intravoxel incoherent motion (IVIM), dynamic contrast-enhanced (DCE) MRI, and F-FDG-PET/CT imaging parameters capturing tumor characteristics and (II) their predictive value of locoregional recurrence-free survival (LRFS) and overall survival (OS) in patients with head and neck squamous cell carcinoma (HNSCC) treated with (chemo)radiotherapy.

METHODS

Between 2014 and 2018, patients with histopathologically proven HNSCC, planned for curative (chemo) radiotherapy, were prospectively included. Pretreatment clinical, anatomical, and functional imaging parameters (obtained by DWI/IVIM, DCE-MRI, and F-FDG-PET/CT) were extracted for primary tumors (PT) and lymph node metastases. Correlations and differences between parameters were assessed. The predictive value of LRFS and OS was assessed, performing univariable, multivariable Cox and CoxBoost regression analyses.

RESULTS

In total, 70 patients were included. Significant correlations between F-FDG-PET parameters and DWI-/DCE volume parameters were found (r > 0.442, p < 0.002). The combination of HPV (HR = 0.903), intoxications (HR = 1.065), PT ADC (HR = 1.252), K (HR = 1.223), and V (HR = 1.215) was predictive for LRFS (C-index = 0.546; p = 0.023). N-stage (HR = 1.058), HPV positivity (HR = 0.886), hypopharyngeal tumor location (HR = 1.111), ADC (HR = 1.102), ADC (HR = 1.137), D* (HR = 0.862), K (HR = 1.106), V (HR = 1.195), SUV (HR = 1.094), and TLG (HR = 1.433) were predictive for OS (C-index = 0.664; p = 0.046).

CONCLUSIONS

Functional imaging parameters, performing DWI/IVIM, DCE-MRI, and F-FDG-PET/CT, yielded complementary value in capturing tumor characteristics. More specific, intoxications, HPV-negative status, large tumor volume-related parameters, high permeability (K), and high extravascular extracellular space (V) parameters were predictive for adverse locoregional recurrence-free survival and adverse overall survival. Low cellularity (high ADC) and high metabolism (high SUV) were additionally predictive for decreased overall survival. These different predictive factors added to estimated locoregional and overall survival.

KEY POINTS

• Parameters of DWI/IVIM, DCE-MRI, and 18F-FDG-PET/CT were able to capture complementary tumor characteristics. • Multivariable analysis revealed that intoxications, HPV negativity, large tumor volume and high vascular permeability (K), and extravascular extracellular space (Ve) were complementary predictive for locoregional recurrence. • In addition to predictive parameters for locoregional recurrence, also high cellularity (low ADC) and high metabolism (high SUV) were complementary predictive for overall survival.

摘要

目的

评估(I)扩散加权(DWI)、体素内不相干运动(IVIM)、动态对比增强(DCE)MRI 和 F-FDG-PET/CT 成像参数与肿瘤特征之间的相关性,以及(II)这些参数对接受(放)化疗的头颈部鳞状细胞癌(HNSCC)患者局部区域无复发生存率(LRFS)和总生存率(OS)的预测价值。

方法

在 2014 年至 2018 年间,前瞻性纳入了经组织病理学证实的 HNSCC 患者,计划进行根治性(放)化疗。为原发肿瘤(PT)和淋巴结转移提取预处理的临床、解剖和功能成像参数(通过 DWI/IVIM、DCE-MRI 和 F-FDG-PET/CT 获得)。评估参数之间的相关性和差异。通过单变量、多变量 Cox 和 CoxBoost 回归分析评估 LRFS 和 OS 的预测价值。

结果

共纳入 70 例患者。发现 F-FDG-PET 参数与 DWI-/DCE 体积参数之间存在显著相关性(r>0.442,p<0.002)。HPV(HR=0.903)、中毒(HR=1.065)、PT ADC(HR=1.252)、K(HR=1.223)和 V(HR=1.215)的组合对 LRFS 具有预测价值(C 指数=0.546;p=0.023)。N 分期(HR=1.058)、HPV 阳性(HR=0.886)、咽下部肿瘤位置(HR=1.111)、ADC(HR=1.102)、ADC(HR=1.137)、D*(HR=0.862)、K(HR=1.106)、V(HR=1.195)、SUV(HR=1.094)和 TLG(HR=1.433)对 OS 具有预测价值(C 指数=0.664;p=0.046)。

结论

进行 DWI/IVIM、DCE-MRI 和 F-FDG-PET/CT 的功能成像参数在捕获肿瘤特征方面具有互补价值。更具体地说,中毒、HPV 阴性状态、与大肿瘤体积相关的参数、高通透性(K)和高细胞外间隙(V)参数与不良局部区域无复发生存和不良总生存相关。低细胞密度(高 ADC)和高代谢(高 SUV)还与降低总生存率相关。这些不同的预测因素增加了对局部区域和总体生存率的估计。

关键点

  • DWI/IVIM、DCE-MRI 和 18F-FDG-PET/CT 的参数能够捕捉互补的肿瘤特征。

  • 多变量分析显示,中毒、HPV 阴性、大肿瘤体积和高血管通透性(K)和细胞外间隙(Ve)是局部区域复发的互补预测因素。

  • 除了局部区域复发的预测因素外,高细胞密度(低 ADC)和高代谢(高 SUV)也是总生存率的互补预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2420/7813703/556232c85eb1/330_2020_7163_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2420/7813703/fc2de79f99cc/330_2020_7163_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2420/7813703/556232c85eb1/330_2020_7163_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2420/7813703/fc2de79f99cc/330_2020_7163_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2420/7813703/556232c85eb1/330_2020_7163_Fig2_HTML.jpg

相似文献

1
Multiparametric functional MRI and F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation.多参数功能磁共振成像和 F-FDG-PET 预测头颈部鳞状细胞癌患者接受(放)化疗的生存情况。
Eur Radiol. 2021 Feb;31(2):616-628. doi: 10.1007/s00330-020-07163-3. Epub 2020 Aug 26.
2
Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.定量扩散加权成像和 18-F-FDG-PET 在头颈部鳞状细胞癌(放化疗)治疗中的预测价值。
Eur J Radiol. 2019 Apr;113:39-50. doi: 10.1016/j.ejrad.2019.01.031. Epub 2019 Feb 4.
3
Correlations between DW-MRI and F-FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo-radiotherapy.头颈部鳞状细胞癌根治性放化疗后 DW-MRI 与 F-FDG PET/CT 参数的相关性。
Cancer Rep (Hoboken). 2021 Aug;4(4):e1360. doi: 10.1002/cnr2.1360. Epub 2021 May 7.
4
Dynamic contrast-enhanced MRI, diffusion-weighted MRI and F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.动态对比增强磁共振成像、扩散加权磁共振成像及F-FDG PET/CT用于预测接受放化疗的口咽或下咽鳞状细胞癌患者的生存率
Eur Radiol. 2016 Nov;26(11):4162-4172. doi: 10.1007/s00330-016-4276-8. Epub 2016 Feb 24.
5
Use of Diffusion-Weighted Imaging and F-Fluorodeoxyglucose Positron Emission Tomography Combined With Computed Tomography in the Response Assessment for (Chemo)radiotherapy in Head and Neck Squamous Cell Carcinoma.弥散加权成像和 F-氟代脱氧葡萄糖正电子发射断层扫描与计算机断层扫描联合应用于头颈部鳞状细胞癌放化疗反应评估。
Clin Oncol (R Coll Radiol). 2018 Dec;30(12):780-792. doi: 10.1016/j.clon.2018.09.007. Epub 2018 Oct 11.
6
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.头颈部鳞状细胞癌的肿瘤代谢和灌注:1H 磁共振波谱、动态对比增强 MRI 和 [18F]FDG-PET 的预处理多模态成像。
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):299-307. doi: 10.1016/j.ijrobp.2010.11.022. Epub 2011 Jan 13.
7
Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma.头颈部鳞状细胞癌定量成像参数的评估。
Q J Nucl Med Mol Imaging. 2022 Jun;66(2):162-170. doi: 10.23736/S1824-4785.19.03179-0. Epub 2019 Sep 5.
8
The Correlations Between MRI Perfusion, Diffusion Parameters, and 18F-FDG PET Metabolic Parameters in Primary Head-and-Neck Cancer: A Cross-Sectional Analysis in Single Institute.原发性头颈癌的MRI灌注、扩散参数与18F-FDG PET代谢参数之间的相关性:单机构横断面分析
Medicine (Baltimore). 2015 Nov;94(47):e2141. doi: 10.1097/MD.0000000000002141.
9
Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review.(放化疗)早期功能成像预测头颈部鳞状细胞癌的反应:系统综述。
Oral Oncol. 2019 Jan;88:75-83. doi: 10.1016/j.oraloncology.2018.11.005. Epub 2018 Nov 22.
10
Early Response Prediction of Multiparametric Functional MRI and F-FDG-PET in Patients with Head and Neck Squamous Cell Carcinoma Treated with (Chemo)Radiation.多参数功能磁共振成像和F-FDG-PET对接受(化疗)放疗的头颈部鳞状细胞癌患者的早期反应预测
Cancers (Basel). 2022 Jan 3;14(1):216. doi: 10.3390/cancers14010216.

引用本文的文献

1
Reduced field-of-view DWI outperforms conventional DWI in assessing tumor heterogeneity and HPV status in head and neck cancer.缩小视野扩散加权成像(DWI)在评估头颈癌的肿瘤异质性和人乳头瘤病毒(HPV)状态方面优于传统DWI。
Sci Rep. 2025 Aug 29;15(1):31889. doi: 10.1038/s41598-025-17284-8.
2
Predicting and monitoring response to head and neck cancer radiotherapy using multimodality imaging and radiobiological digital twin simulations.使用多模态成像和放射生物学数字孪生模拟预测和监测头颈癌放疗反应
Phys Med Biol. 2025 May 27;70(11). doi: 10.1088/1361-6560/add9de.
3
Reduced-distortion diffusion weighted imaging for head and neck radiotherapy.

本文引用的文献

1
Pretreatment Intra-Voxel Incoherent Motion Diffusion-Weighted Imaging (IVIM-DWI) in Predicting Induction Chemotherapy Response in Locally Advanced Hypopharyngeal Carcinoma.治疗前体素内不相干运动扩散加权成像(IVIM-DWI)预测局部晚期下咽癌诱导化疗反应的研究
Medicine (Baltimore). 2016 Mar;95(10):e3039. doi: 10.1097/MD.0000000000003039.
2
The Correlations Between MRI Perfusion, Diffusion Parameters, and 18F-FDG PET Metabolic Parameters in Primary Head-and-Neck Cancer: A Cross-Sectional Analysis in Single Institute.原发性头颈癌的MRI灌注、扩散参数与18F-FDG PET代谢参数之间的相关性:单机构横断面分析
Medicine (Baltimore). 2015 Nov;94(47):e2141. doi: 10.1097/MD.0000000000002141.
3
用于头颈部放射治疗的低失真扩散加权成像
Phys Imaging Radiat Oncol. 2024 Sep 23;32:100653. doi: 10.1016/j.phro.2024.100653. eCollection 2024 Oct.
4
Longitudinal Alzheimer's Disease Progression Prediction With Modality Uncertainty and Optimization of Information Flow.基于模态不确定性和信息流优化的阿尔茨海默病纵向进展预测
IEEE J Biomed Health Inform. 2025 Jan;29(1):259-272. doi: 10.1109/JBHI.2024.3472462. Epub 2025 Jan 7.
5
Prognostic value of pretreatment radiological MRI variables and dynamic contrast-enhanced MRI on radiotherapy treatment outcome in laryngeal and hypopharyngeal tumors.治疗前放射学磁共振成像(MRI)变量及动态对比增强MRI对喉癌和下咽癌放射治疗结果的预后价值
Clin Transl Radiat Oncol. 2024 Sep 12;49:100857. doi: 10.1016/j.ctro.2024.100857. eCollection 2024 Nov.
6
Effectiveness of magnetic resonance imaging and spiral computed tomography in the staging and treatment prognosis of colorectal cancer.磁共振成像与螺旋计算机断层扫描在结直肠癌分期及治疗预后评估中的有效性
World J Gastrointest Surg. 2024 Jul 27;16(7):2135-2144. doi: 10.4240/wjgs.v16.i7.2135.
7
Multi-modality imaging parameters that predict rapid tumor regression in head and neck radiotherapy.预测头颈部放疗中肿瘤快速消退的多模态成像参数。
Phys Imaging Radiat Oncol. 2024 Jun 24;31:100603. doi: 10.1016/j.phro.2024.100603. eCollection 2024 Jul.
8
Chemokine Receptor-4 Targeted PET/CT Imaging with Ga-Pentixafor in Head and Neck Cancer-A Comparison with F-FDG and CXCR4 Immunohistochemistry.用镓标记的喷替沙氟进行趋化因子受体-4靶向PET/CT成像在头颈癌中的应用——与氟代脱氧葡萄糖及CXCR4免疫组化的比较
Diagnostics (Basel). 2024 Jun 28;14(13):1375. doi: 10.3390/diagnostics14131375.
9
Relating pre-treatment non-Gaussian intravoxel incoherent motion diffusion-weighted imaging to human papillomavirus status and response in oropharyngeal carcinoma.将治疗前非高斯体素内不相干运动扩散加权成像与口咽癌中的人乳头瘤病毒状态及反应相关联。
Phys Imaging Radiat Oncol. 2024 Apr 4;30:100574. doi: 10.1016/j.phro.2024.100574. eCollection 2024 Apr.
10
Changes in serial multiparametric MRI and FDG-PET/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer.在头颈部癌症患者的放射治疗过程中,系列多参数 MRI 和 FDG-PET/CT 功能成像的变化可预测治疗反应。
Eur Radiol. 2023 Dec;33(12):8788-8799. doi: 10.1007/s00330-023-09843-2. Epub 2023 Jul 5.
Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
动态对比增强磁共振成像(MRI)、扩散加权MRI和18F-氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(PET/CT)多模态成像在预测接受放化疗的口咽或下咽鳞状细胞癌颈部控制情况中的临床应用
PLoS One. 2014 Dec 22;9(12):e115933. doi: 10.1371/journal.pone.0115933. eCollection 2014.
4
Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.动态对比增强磁共振成像预测接受放化疗的口咽或下咽鳞状细胞癌的局部控制。
PLoS One. 2013 Aug 7;8(8):e72230. doi: 10.1371/journal.pone.0072230. eCollection 2013.